found that fast escalation to 8 mg produced GI adverse events in 50% of participants, compared to roughly 35% with gradual titration (Rosenstock et al., Lancet, 2023)
Patients should report nausea that prevents adequate food or fluid consumption, as this may lead to dehydration or nutritional deficiencies
In addition, current research highlights that Semaglutide provides greater results in terms of weight loss when compared to liraglutide
Active inflammation, recent flares, or severe malnutrition generally contraindicate GLP-1 therapy
GLP-1 GLP-1(-1) 1 GLP-1DPP-4GLP-1DPP-41GLP-120202GLP-1GLP-1 2023418GLP-1/GIP1: GLP-1GLP-1GIPGLP-1GIPGLP-12024316243 GLP-1 () GLP-1 () GLP-1 () 1GIP/GLP-1GIPKGLP-1LGLP-1GIPGLP-1(1) GIPGLP-1 7GIPGLP-1()32GIPGLP-1(2) 15mg12.5mg415mg15mg42.5mg115mg 1mgSURPASS-2405 mg10 mg15 mg1 mg HbA1c5 mg -2.09%10 mg -2.37%15 mg -2.46% -1.86%31mg(3)1mg5mg1mgHbA1c 5 mg -7.8 kg10 mg -10.3 kg15 mg -12.4kg1mg -6.2kgHbA1c31mg(4)1mg5mgHbA1c1mg 15 mg 63.6%10 mg 68.7%15 mg 68.9% 64.2% 1722%18% 1316%12% 610%8%(5)54 mg/dL 0.6%5 mg0.2%10 mg1.7%15 mg 0.4% GLP-1GLP-1 GLP-1 GIP/GLP-1

Further, the -helix fractions ( f a ) of SR18 calculated at 222 were found to be in the range of 0.034 in 1X PBS, 0.12 in 20% TFE, 0.22 in 20% HFIP, and 0.17 in 30 mM SDS (Supplementary Table S2), which is noted to be comparable with the reported value of 0.027 for semaglutide ( FIGURE 9 Further, Dynamic Light Scattering (DLS), a widely used technique for determining the hydrodynamic size and size distribution of molecules in a sample by analyzing fluctuations in scattered light due to Brownian motion, was used to evaluate the hydrodynamic size distribution of 100 M SR18 under different solvent conditions